Data Sheet 9_Lactobacillus rhamnosus GG attenuates MASLD/MASH progression by modulating gut microbiota and metabolic pathways.zip by Shi-Long Wang (2229925)

“…Dysbiosis of the gut microbiota plays a significant role in chronic liver diseases, making probiotic treatment a focal point in MASLD research. …”

Data Sheet 6_Lactobacillus rhamnosus GG attenuates MASLD/MASH progression by modulating gut microbiota and metabolic pathways.zip by Shi-Long Wang (2229925)

“…Dysbiosis of the gut microbiota plays a significant role in chronic liver diseases, making probiotic treatment a focal point in MASLD research. …”

Table 1_A high-accuracy, low-cost blood test for Alzheimer’s disease: validating P-tau181/Aβ42 in real-world cohorts.xlsx by Dequan Liu (1788469)

“…Plasma P-tau181 and Aβ42 levels were measured using flow cytometry and cross-validated with Single-molecule Array (SIMOA). …”

Data Sheet 1_Lactobacillus rhamnosus GG attenuates MASLD/MASH progression by modulating gut microbiota and metabolic pathways.zip by Shi-Long Wang (2229925)

“…Dysbiosis of the gut microbiota plays a significant role in chronic liver diseases, making probiotic treatment a focal point in MASLD research. …”

Data Sheet 3_Lactobacillus rhamnosus GG attenuates MASLD/MASH progression by modulating gut microbiota and metabolic pathways.zip by Shi-Long Wang (2229925)

“…Dysbiosis of the gut microbiota plays a significant role in chronic liver diseases, making probiotic treatment a focal point in MASLD research. …”

Data Sheet 7_Lactobacillus rhamnosus GG attenuates MASLD/MASH progression by modulating gut microbiota and metabolic pathways.zip by Shi-Long Wang (2229925)

“…Dysbiosis of the gut microbiota plays a significant role in chronic liver diseases, making probiotic treatment a focal point in MASLD research. …”

Data Sheet 8_Lactobacillus rhamnosus GG attenuates MASLD/MASH progression by modulating gut microbiota and metabolic pathways.zip by Shi-Long Wang (2229925)

“…Dysbiosis of the gut microbiota plays a significant role in chronic liver diseases, making probiotic treatment a focal point in MASLD research. …”

Data Sheet 5_Lactobacillus rhamnosus GG attenuates MASLD/MASH progression by modulating gut microbiota and metabolic pathways.zip by Shi-Long Wang (2229925)

“…Dysbiosis of the gut microbiota plays a significant role in chronic liver diseases, making probiotic treatment a focal point in MASLD research. …”

Data Sheet 4_Lactobacillus rhamnosus GG attenuates MASLD/MASH progression by modulating gut microbiota and metabolic pathways.zip by Shi-Long Wang (2229925)

“…Dysbiosis of the gut microbiota plays a significant role in chronic liver diseases, making probiotic treatment a focal point in MASLD research. …”

<b>miR-214 and its primary transcript Dnm3os</b><b> </b><b>regulate fibrosis and inflammation through RAGE signalling in</b><b> diabetic kidney disease</b> by Shinji Hagiwara (13598935)

“…<p dir="ltr">Pathological signaling via the receptor for advanced glycation end-products (RAGE) is critical in diabetic kidney disease (DKD) development, while RAGE deletion is reno-protective. …”

Table 1_Effects and safety of Salvia miltiorrhiza on the improvement of renal function, inflammatory factors, and vascular endothelium in patients with diabetic kidney disease: a m... by Shuyu Zheng (5570231)

“…Notably, the safety profile remained sound, with no significant differences in adverse event rates between the two groups (P > 0.05).…”

Data Sheet 3_Effects and safety of Salvia miltiorrhiza on the improvement of renal function, inflammatory factors, and vascular endothelium in patients with diabetic kidney disease... by Shuyu Zheng (5570231)

“…Notably, the safety profile remained sound, with no significant differences in adverse event rates between the two groups (P > 0.05).…”

Data Sheet 1_Effects and safety of Salvia miltiorrhiza on the improvement of renal function, inflammatory factors, and vascular endothelium in patients with diabetic kidney disease... by Shuyu Zheng (5570231)

“…Notably, the safety profile remained sound, with no significant differences in adverse event rates between the two groups (P > 0.05).…”

Data Sheet 2_Effects and safety of Salvia miltiorrhiza on the improvement of renal function, inflammatory factors, and vascular endothelium in patients with diabetic kidney disease... by Shuyu Zheng (5570231)

“…Notably, the safety profile remained sound, with no significant differences in adverse event rates between the two groups (P > 0.05).…”

Image1_Clinical performance of a novel and rapid bioassay for detection of thyroid-stimulating immunoglobulins in Graves’ orbitopathy patients: a comparison with two commonly used... by Gijsbert J. Hötte (4971547)

“…Turbo TSI (p<0.001) and TBII (p<0.01) levels were higher in patients with active compared to inactive GO. …”

Image4_Clinical performance of a novel and rapid bioassay for detection of thyroid-stimulating immunoglobulins in Graves’ orbitopathy patients: a comparison with two commonly used... by Gijsbert J. Hötte (4971547)

“…Turbo TSI (p<0.001) and TBII (p<0.01) levels were higher in patients with active compared to inactive GO. …”

Image3_Clinical performance of a novel and rapid bioassay for detection of thyroid-stimulating immunoglobulins in Graves’ orbitopathy patients: a comparison with two commonly used... by Gijsbert J. Hötte (4971547)

“…Turbo TSI (p<0.001) and TBII (p<0.01) levels were higher in patients with active compared to inactive GO. …”

Image2_Clinical performance of a novel and rapid bioassay for detection of thyroid-stimulating immunoglobulins in Graves’ orbitopathy patients: a comparison with two commonly used... by Gijsbert J. Hötte (4971547)

“…Turbo TSI (p<0.001) and TBII (p<0.01) levels were higher in patients with active compared to inactive GO. …”

Table 1_Effect of high-intensity intermittent rehabilitation training on physical function, gut microbiome and metabolite after percutaneous coronary intervention in patients with... by Lei Jiang (73366)

“…</p>Results<p>The 6MWT showed significantly greater improvement in the HIIT group compared to the MCT group (P = 0.0024). …”

Data Sheet 1_Global burden of cancer in adolescents and young adults aged 10–24 years: a trend analysis.pdf by Junjun Yang (307892)

“…The age-standardized death rate(ASDR) and age-standardized DALY rate of total cancer have decreased significantly globally in adolescents and young adults aged 10–24 years. …”